FDA Approves PURELAX — CVS Pharmacy

CVS Pharmacy announced the approval of ANDA090685 for PURELAX (polyethylene glycol 3350) on October 6, 2009, marking a significant move that intensified competition in the over-the-counter laxative market. This approval, which disrupts the market held by established branded rivals, is anticipated to drive a significant expansion in market share for CVS Pharmacy within the consumer healthcare sector.